Aug 21 (Reuters) - OssDsign AB OSSD.ST :
* OSSDSIGN REPORTS SUCCESSFUL OUTCOME AT 6-MONTH FOLLOW-UP
OF
CLINICAL STUDY ON SINUS AUGMENTATION
* STUDY REPRESENTS FIRST USE OF OSSDSIGN'S PROPRIETARY
CALCIUM
PHOSPHATE MATERIAL IN ORAL CAVITY.
* GLOBAL MARKET FOR DENTAL MEMBRANES AND BONE GRAFT
SUBSTITUTES AT
$ 620 MILLION IN 2018 ACCORDING TO REPORT BY TRANSPARENCY MARKET
RESEARCH
Source text for Eikon: ID:nWkr315gdz
Further company coverage: OSSD.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))